pancreatic tissues and fluids suggests multiple sites of insulin production. Immunoreactive insulin occurs in human saliva and concentrations increase after oral glucose ingestion. The goal of these experiments was to determine whether the presence of immunoreactive insulin in this extra-pancreatic site is independent of pancreatic production or merely represents the accumulation of circulating pancreatic insulin. The mean _+ SEM concentration of extracted salivary immunoreactive insulin in five normal volunteers increased during an oral glucose tolerance test from basal values of 36_+ 3.0 to 291 _+ 40 pmol/1; however, the peak occurred 45-90 rain later than in serum. On this basis, it was not possible to distinguish between the stimulation (by increased blood glucose concentrations) of insulin synthesis in the saliva glands from the accumulation of blood insulin. Therefore, we studied a group of five volunteers during intravenous infusion of insulin (1 and 10mU.kg -1 .min -1, sequentially) and glucose (euglycaemic clamp). Under these conditions, salivary irnmunoreactive insulin concentrations increased significantly from 254_+ 100 to 1919 + 437 pmol/1 (p < 0.05), while simultaneous mean plasma C-peptide concentrations were unchanged. Thus, the concentration of salivary immunoreactive insulin was clearly related to the amount of insulin in the blood and not to the plasma glucose concentration. Physico-chemical and immunological characterization of salivary immunoreactive insulin by dilution in radioimmunoassay, gel filtration and polyacrylamide disc gel electrophoresis demonstrated that the majority of it was indistinguishable from insulin standards. We conclude that salivary insulin is accumulated from the blood and there is no reason to suggest that it is synthesized elsewhere than in the pancreas.
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pancreatic tissues and fluids suggests multiple sites of insulin production. Immunoreactive insulin occurs in human saliva and concentrations increase after oral glucose ingestion. The goal of these experiments was to determine whether the presence of immunoreactive insulin in this extra-pancreatic site is independent of pancreatic production or merely represents the accumulation of circulating pancreatic insulin. The mean _+ SEM concentration of extracted salivary immunoreactive insulin in five normal volunteers increased during an oral glucose tolerance test from basal values of 36_+ 3.0 to 291 _+ 40 pmol/1; however, the peak occurred 45-90 rain later than in serum. On this basis, it was not possible to distinguish between the stimulation (by increased blood glucose concentrations) of insulin synthesis in the saliva glands from the accumulation of blood insulin. Therefore, we studied a group of five volunteers during intravenous infusion of insulin (1 and 10mU.kg -1 .min -1, sequentially) and glucose (euglycaemic clamp). Under these conditions, salivary irnmunoreactive insulin concentrations increased significantly from 254_+ 100 to 1919 + 437 pmol/1 (p < 0.05), while simultaneous mean plasma C-peptide concentrations were unchanged. Thus, the concentration of salivary immunoreactive insulin was clearly related to the amount of insulin in the blood and not to the plasma glucose concentration. Physico-chemical and immunological characterization of salivary immunoreactive insulin by dilution in radioimmunoassay, gel filtration and polyacrylamide disc gel electrophoresis demonstrated that the majority of it was indistinguishable from insulin standards. We conclude that salivary insulin is accumulated from the blood and there is no reason to suggest that it is synthesized elsewhere than in the pancreas.
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High concentrations of immunoreactive insulin (IRI) occur in several extra-pancreatic sites, including the brain [1, 2] , parotid gland [3] [4] [5] , fibroblasts [1] , bile [6] , lymphocytes [1] and saliva [3, 5] . This may be explained by extra-pancreatic hormone synthesis, concentration of circulating insulin or the presence of immunologically-related, cross-reacting compounds.
Of the various different sites, we have chosen to characterize salivary IRI because of the relative ease of repeated sample collection in human volunteers. Furthermore, the concentration of salivary IRI varies after fl-cell stimulation, such as oral glucose [3, 5] . The dynamic nature of salivary IRI thus allowed us to test whether changes in concentration are solely dependent on pancreatic insulin production by use of the euglycaemic, hyperinsulinaemic clamp technique [7] . We have also characterized extractable salivary insulin by a variety of immunochemical and physico-chemical techniques. Taken together, the data presented indicate that the origin of salivary insulin is largely, if not entirely, the pancreatic fl cell.
Subjects and methods

Subjects
Five male subjects underwent an oral glucose tolerance test; they were healthy, non-obese, between 25 and 35 years of age, and had no first-degree relatives with diabetes mellitus. Another group of volunteers was studied during the insulin clamp; it was composed of four obese, drug-free, glucose intolerant males and one healthy, non-obese male (mean age 36_+ 1.1 years). The procedure had the approval of the Institutional Review Board and informed consent was obtained from all subjects. The latter group of volunteers was participating in a study on the effect of glycogen-depleting exercise and samples were obtained before exercise.
Glucose tolerance test
Subjects were prepared for the oral glucose tolerance test by taking a balanced diet containing at least 150 g/day of carbohydrate for the 3 days before the test. After an overnight fast, 100 g of glucose was taken by mouth in < 15 min. Venous blood (for plasma glucose and serum insulin measurements) was withdrawn immediately before taking the oral glucose (0 min) and 30, 60, 75, 90, 120, 150 and 180 rain afterwards. At each time, the subject was instructed to produce 3-5 ml 
Insulin clamp
The details of the insulin clamp procedure have been published elsewhere [7] . Briefly, after administering a priming bolus of insulin, intravenous insulin was infused at a constant rate (1.0 mU.kg -1 .rain -1) for 100rain. At this time, a second primed, continuous infusion (10.0 mU. kg -1. min -1) was started and continued for an additional 100rain. The plasma glucose concentration was measured every 5-7 rain and maintained at fasting concentrations (5.0 + 0.3 mmol/l) by servo-controlled, variable rate infusion of 20% D-glucose. Blood and saliva samples were collected for measurement of immunoreactive insulin or C-peptide after an overnight fast (0 min) and at 100 and 200 rain during the clamp procedure.
Analytical methods
Plasma glucose levels were determined by the glucose oxidase method using a glucose autoanalyzer (Beckman, Fullerton, California, USA). Serum IRI was measured by a modification of the method of Starr and Rubenstein [8] , using porcine insulin standards (Eli Lilly, Indianapolis, Indiana, USA) and polyethylene glycol (mol.wt. 6000), 12.5% final concentration to separate the bound from the free 125I-insulin tracer. Plasma C-peptide reactivity from samples obtained during the clamp were measured by radioimmunoassay [8] , using antisera GP 644 (a gift from Dr. A. H. Rubenstein, Chicago). IRI in saliva was extracted before analysis by treatment with acidalcohol. Before extraction, food fragments and cellular detritus were removed from the freshly collected samples by centrifugation (1000 g for 30 rain at 4~ The sample was then diluted to twice its volume with ice-cold 0.1 mol/1 HCI-75% ethanol. The mixture was placed in an ice-bath for 2 h and vigorously agitated every 20 rain. The incubation was terminated by centrifugation (1000 g for 30 min at 4 ~ and the supernatant removed with siliconized Pasteur pipettes. The supernatant was then evaporated to dryness under vacuum and reconstituted to the original sample volume in either radioimmunoassay buffer or 0.1 mol/l N-ethylmorpholine (Aldrich Chemicals, Milwaukee, Wisconsin, USA), depending on the subsequent analytical procedures. The samples were stored at -20 ~ The recovery of salivary IRI was estimated by the addition of 1251-insulin (< 1000 cpm) to a separate aliquot of saliva from each volunteer. The extracted radioactivity was compared with the amount added and the integrity of the recovered 12sI-insulin was assessed by precipitation in 12% trichloroacetic acid. Recovery ranged from 42 to 63% (mean 52%), and 89 to 95% of the recovered insulin tracer was precipitable in trichloroacetic acid and thus judged undamaged on the basis of this procedure. Concentrations of salivary IRI are reported as that which were recovered and no adjustments were made for rates of saliva production.
The extracted insulin was analyzed by gel filtration chromatography and polyacrylamide disc gel electrophoresis (PAGE). The elution position of salivary IRI was determined by applying 1.0 ml of the extract to the top of a column (1.5 x 75 cm, Bio-Rad P-30 fine, Richmond, California, USA) equilibrated in 0.1 mol/l Tris-HC1, 0.25% bovine serum albumin, pH 7.6. Fractions (1 ml) were collected and the IRI was measured in each fraction (0-60 ml). The elution volume of salivary IRI was compared with the position of usI-insulin column marker added on a separate occasion and eluted under otherwise identical conditions.
Ten percent polyacrylamide gels (pH 8.7), prepared according to the method of Davis [9] , were poured into siliconized glass columns (0.7 x 15 cm). The running gel filled 9.5 cm and the stacking gel nol blue dye added to each sample served as a column marker. The relative mobility (R0 of IRI in gels was calculated as a ratio of the position in the running gel to the leading edge of the marker dye. Direct current (3.5 mA/gel, negative pole at the origin) was applied until the marker dye reached a point 4.5 cm from the origin. The gel was then removed from the column and divided into slices of 1.25 mm width. Each slice was placed into 0,5 ml of radioimmunoassay buffer and incubated for 48 h before IRI was measured in an aliquot of the incubate. The Rf of salivary IRI was compared with that of human standards analyzed in the same batch.
Statistical methods
Results are expressed as mean + SEM. Differences between means were compared by use of the two-tailed Student's t-test for paired values.
Results
The plasma glucose concentrations after 100 g oral glucose ingestion were within the normal range [10] (Fig. 1 A) . During the test, serum IRI increased from a basal level of 36 + 8 pmol/1 to a peak of 480 +_ 53 pmol/1 30 min after ingestion of glucose (Fig. 1 C) . qflae simultaneous concentrations of salivary IRI are shown in Figure I B. Basal concentrations were initially undetectable (<17.5pmol/1) but increased during the oral glucose tolerance test to 291 +78 pmol/1, but with a 45-90 min delay relative to the peak in serum IRI. During the euglycaemic clamping procedure, the plasma glucose concentrations, measured every 5-7 min, were held constant (5.0 +_ 0.3 mmol/1; Fig. 2 ). After 200 rain of the high-dose insulin infusion, the mean plasma C-peptide reactivity was 330 + 70 pmol/1, statistically unchanged from basal concentrations (510+_60pmol/1; 0.1 >p>0.05; Fig.2A) . However, the mean serum insulin concentrations increased significantly from 176 ___ 51 to 36,796 +_ 2031 pmol/1 at 200 rain during infusion of 10mU.kg-l.min -1 insulin (p< 0.001 ; Fig. 2 B) , and there was a significant increase in the concentration of salivary IRI from 253 +100 to 1919 + 437 pmol/1 (p < 0.05; Fig. 2 C) .
The extractable purified salivary IRI collected during the oral glucose tolerance test was characterized by its behaviour in radioimmunoassay, gel filtration chromatography and PAGE. Multiple dilutions of salivary IRI (log-logit slope=-0.90) in radioimmunoassay were indistinguishable from the insulin standards (loglogit slope = -0.95; Fig. 3) . Likewise, the elution position of salivary IRI on gel filtration was indistinguishable from the insulin standard (Fig. 4) , and this indicated that the material was similar in size and molecular weight to native insulin. Finally, samples of salivary IRI were analyzed by separation on PAGE (Fig. 5) . In each instance, the major peak of IRI had the same Rf as the human insulin standard, and thus the net charge of salivary IRI is identical to insulin. Several minor peaks of both lesser and greater mobility were inconsistently detected, suggesting the presence of insulin fragments or deamidated-insulin.
G. Vallejo et al.: Salivary immunoreactive insulin of IRI. At least in the case of the Salivary glands, blood insulin is actively caught up in the process of fluid accumulation and any further role for it is purely speculative. Although we cannot exclude totally small amounts of extra-pancreatic insulin synthesis, our data should re-emphasize the fact that large concentrations of IRI in such sites are not sufficient proof of local synthesis. Ultimate proof of such a process will require the isolation of local cytoplasmic pre-proinsulin mRNA. 
Acknowledgements
Discussion
This report confirms previous observations of IRI in saliva and the relatively delayed changes in its concentration in comparison to serum insulin after glucose challenge [3, 5] . However, it has not been possible to distinguish between the movement of blood insulin into saliva from the intriguing possibility that insulin is produced in situ and its synthesis is related to changes in plasma glucose concentrations. Histological and embryonic similarities between the pancreas and salivary glands lends support to the latter hypothesis.
In this report we show that the appearance of salivary IRI is clearly related to, and may be solely dependent upon, the pancreatic production of insulin. Under conditions of steady-state plasma glucose levels and extraordinarily high blood insulin concentrations, there was a significant rise in the level of salivary IRI while there was no change, or a probable decrease, in the rate of endogenous insulin release.
As with other investigators [1] , we find that the majority of extractable salivary IRI is indistinguishable from insulin standards and is thus not a cross-reacting compound. It should also be pointed out in this regard that we were unable to examine all IRI in saliva: only 50% of the total was extracted (based on our assumption that 125I-insulin behaves like salivary IRI). It can be argued that certain forms of IRI may be selectively lost during extraction and therefore escape detection and analysis. This speculation will require further investigation.
Our approach to the presence of IRI in an unusual site is undoubtedly applicable to other tissues and body fluids known to contain relatively high concentrations
